• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BSX
Click for more information
5.41% 3.5¢

BLACKSTONE MINERALS LIMITED - Charts / Financials

Market Cap $18.47M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

BSX, an international portfolio of battery and precious metals exploration projects.... BSX, an international portfolio of battery and precious metals exploration projects. BSX’s core focus is the Ta Khoa Project located in SE Asia's premiere nickel sulfide district, where drilling has intersected substantial disseminated mineralisation including 45.5m @ 1.2% nickel sulfides.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 01/10/2024 (20 minute delay) ?
Day
Open 3.5¢   Day High 3.5¢   Day Low 3.0¢
Daily Volume 850753
Bids   Sellers
Number Price Volume   Number Price Volume
1 3.3¢ 50000   1 3.5¢ 4843

Directors & Senior Management

Mr. Hamish Peter Halliday Non-Executive Chairman of the Board
Mr. Scott Williamson Managing Director, Director
Mr. Jamie Byrde Chief Financial Officer, Company Secretary
Mr. Scott Williamson Managing Director, Executive Director
Mr. Andrew Strickland Executive
Mr. Hamish Peter Halliday Non-Executive Chairman of the Board
Dr. Frank Peter Bierlein Non-Executive Director
Ms. Alison Gaines Non-Executive Independent Director
Mr. Daniel Richard Lougher Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
3.5¢ 		Change
-0.002(5.41%) 		Mkt cap ! $18.47M
Open High Low Value Volume
3.5¢ 3.5¢ 3.0¢ $27.93K 850.7K

Buyers (Bids)

No. Vol. Price($)
1 50000 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 4843 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
Last
3.5¢ 		  Change
-0.002 ( 2.78 %)
Open High Low Volume
3.5¢ 3.5¢ 3.1¢ 183108
Last updated 15.59pm 01/10/2024 ?

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.